HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Playtex

This article was originally published in The Rose Sheet

Executive Summary

Playtex: Haas Wheat & Harrison Investment Partners will acquire 40% of Playtex' outstanding common stock with the completion of a definitive agreement whereby Playtex will sell the investment group 20 mil. shares of newly issued common stock for $9 per share. The $9 per share price represents a 20% premium over the average closing price of Playtex's common stock from March 1-16, Playtex notes, adding that the $180 mil. proceeds will be used to reduce senior debt. In association with the equity investment, Playtex and Haas Wheat have obtained a commitment from Chemical Bank for a $500 mil. senior credit package that "replace the existing bank debt at substantially reduced interest rates" and will give Playtex "in excess of $125 mil. of cash and available borrowing facilities." After the investment is completed, Haas Wheat Chairman Robert Haas is expected to become chairman of Playtex, replacing chairman and CEO Joel Smilow, who will assume the titles of chairman of the executive committee and director...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001477

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel